GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Helix BioPharma Corp (FRA:HBP0) » Definitions » Scaled Net Operating Assets

Helix BioPharma (FRA:HBP0) Scaled Net Operating Assets : -1.06 (As of Oct. 2024)


View and export this data going back to . Start your Free Trial

What is Helix BioPharma Scaled Net Operating Assets?

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

Helix BioPharma's operating assets for the quarter that ended in Oct. 2024 was €0.12 Mil. Helix BioPharma's operating liabilities for the quarter that ended in Oct. 2024 was €1.19 Mil. Helix BioPharma's Total Assets for the quarter that ended in Jul. 2024 was €1.00 Mil. Therefore, Helix BioPharma's scaled net operating assets (SNOA) for the quarter that ended in Oct. 2024 was -1.06.


Helix BioPharma Scaled Net Operating Assets Historical Data

The historical data trend for Helix BioPharma's Scaled Net Operating Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Helix BioPharma Scaled Net Operating Assets Chart

Helix BioPharma Annual Data
Trend Jul15 Jul16 Jul17 Jul18 Jul19 Jul20 Jul21 Jul22 Jul23 Jul24
Scaled Net Operating Assets
Get a 7-Day Free Trial Premium Member Only Premium Member Only -1.11 -0.29 -0.13 -0.40 -1.12

Helix BioPharma Quarterly Data
Jan20 Apr20 Jul20 Oct20 Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24 Apr24 Jul24 Oct24
Scaled Net Operating Assets Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -1.00 -0.20 -3.11 -1.01 -1.06

Competitive Comparison of Helix BioPharma's Scaled Net Operating Assets

For the Biotechnology subindustry, Helix BioPharma's Scaled Net Operating Assets, along with its competitors' market caps and Scaled Net Operating Assets data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Helix BioPharma's Scaled Net Operating Assets Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Helix BioPharma's Scaled Net Operating Assets distribution charts can be found below:

* The bar in red indicates where Helix BioPharma's Scaled Net Operating Assets falls into.



Helix BioPharma Scaled Net Operating Assets Calculation

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

Helix BioPharma's Scaled Net Operating Assets (SNOA) for the fiscal year that ended in Jul. 2024 is calculated as

Scaled Net Operating Assets (SNOA)(A: Jul. 2024 )
=(Operating Assets (A: Jul. 2024 )-Operating Liabilities (A: Jul. 2024 ))/Total Assets (A: Jul. 2023 )
=(0.274-1.062)/0.704
=-1.12

where

Operating Assets(A: Jul. 2024 )
=Total Assets - Cash, Cash Equivalents, Marketable Securities
=1.001 - 0.727
=0.274

Operating Liabilities(A: Jul. 2024 )
=Total Liabilities - Long-Term Debt & Capital Lease Obligation - Short-Term Debt & Capital Lease Obligation
=1.062 - 0 - 0
=1.062

Helix BioPharma's Scaled Net Operating Assets (SNOA) for the quarter that ended in Oct. 2024 is calculated as

Scaled Net Operating Assets (SNOA)(Q: Oct. 2024 )
=(Operating Assets (Q: Oct. 2024 )-Operating Liabilities (Q: Oct. 2024 ))/Total Assets (Q: Jul. 2024 )
=(0.124-1.186)/1.001
=-1.06

where

Operating Assets(Q: Oct. 2024 )
=Total Assets - Cash, Cash Equivalents, Marketable Securities
=0.276 - 0.152
=0.124

Operating Liabilities(Q: Oct. 2024 )
=Total Liabilities - Long-Term Debt & Capital Lease Obligation - Short-Term Debt & Capital Lease Obligation
=1.186 - 0 - 0
=1.186

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Helix BioPharma Scaled Net Operating Assets Related Terms

Thank you for viewing the detailed overview of Helix BioPharma's Scaled Net Operating Assets provided by GuruFocus.com. Please click on the following links to see related term pages.


Helix BioPharma Business Description

Traded in Other Exchanges
Address
40 Temperance Street, Suite 2700, Bay Adelaide Centre - North Tower, Toronto, ON, CAN, M5H0B4
Helix BioPharma Corp is a clinical-stage biopharmaceutical company. It is focused on cancer drug development. The company develops therapies in the field of immuno-oncology based on its proprietary technology mainly in the areas of cancer prevention and treatment. Its pipeline candidate is L-DOS47 for Tumor Defence Breaker is in clinical trials for pancreatic cancer.

Helix BioPharma Headlines

No Headlines